The University of Minnesota is teaming up with the American Medical Association on a high profile push to steady public confidence in vaccines, pulling together top doctors and researchers to pore over the latest data and publish clear guidance before the next respiratory season. Working through the university's Vaccine Integrity Project, the partnership will review studies on influenza, COVID-19 and RSV and turn them into practical analyses for clinicians, insurers and state officials, in what university leaders describe as an effort to restore clarity after recent changes to federal vaccine advisory processes.
According to the Star Tribune, the new effort will bring together leading medical societies and public health organizations to review evidence and issue public guidance by summer. Organizers say the reviews are meant to help decision makers interpret the science, not to replace federal recommendations.
A response to federal turmoil
Michael Osterholm, director of the university's Center for Infectious Disease Research and Policy, framed the project as an attempt to plug what he called "a huge black hole" in the current system, according to The Washington Post. AMA leaders say their involvement signals deep concern among physicians about how vaccine evidence is being assessed at the federal level.
What the Vaccine Integrity Project has done
The Vaccine Integrity Project, launched by CIDRAP in 2025, has already convened experts and produced an evidence review of flu, COVID and RSV vaccines last summer and is now expanding that work to additional populations. CIDRAP notes that the initiative is privately funded and is focused on generating timely clinical tools and gap analyses for frontline providers.
Minnesota already diverged from CDC
Minnesota health officials have already parted ways with some federal guidance, issuing standing orders that broaden pharmacists' authority to give COVID-19 shots and shifting state recommendations to line up with professional medical societies. In a January statement, the Minnesota Department of Health said association driven vaccine schedules provide clearer, science based direction for providers and emphasized that routine shots remain covered under existing programs.
Vaccine confidence and the HPV dispute
National polling suggests confidence in vaccines has slipped. The Annenberg Public Policy Center recently found that roughly 65 percent of respondents say the COVID-19 vaccine is safe, and trust in the flu shot has declined compared with 2022, according to the Annenberg Public Policy Center.
The Star Tribune reported that the federal Advisory Committee on Immunization Practices recently endorsed a single dose HPV schedule for some preteens and teens, a move that prompted a separate HPV review at the university, and that Minnesota's flu uptake this winter lagged, with about 31 percent of residents and 63 percent of seniors getting a flu shot.
Legal and policy note
HHS spokesman Andrew Nixon told The Washington Post that ACIP "remains the nation's advisory body for vaccine recommendations driven by gold standard science" and cautioned that outside analyses do not replace the federal process. The back and forth underscores the tension between an official advisory panel and independent reviews that states and insurers will now have to factor into coverage decisions and clinic policies.
What to watch next
The university led reviews are expected to release guidance by summer. While the findings will not be binding, they could carry weight with employers setting vaccine rules, insurers deciding what to cover and state officials updating their own recommendations. Healthcare industry coverage has noted that the project is designed to fill analytical gaps and could shape how clinicians talk with patients heading into the fall respiratory season, according to Becker's Hospital Review.
